TScan Therapeutics, Inc. Deferred Revenue, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-12
- 2026-06-30: Deferred Revenue, Current $586.00K.
- 2026-03-31: Deferred Revenue, Current $1.64M.
- 2025-12-31: Deferred Revenue, Current $2.62M.
- 2025-09-30: Deferred Revenue, Current $5.19M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2026-06-30 | $586.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.64M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.62M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $5.19M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $7.70M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $10.27M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $11.70M 10-K · filed 2026-03-04 |
| 2024-09-30 | $9.93M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $10.70M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $10.44M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $10.14M 10-K · filed 2025-03-05 |
| 2023-09-30 | $15.21M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $19.21M 10-Q · filed 2023-08-10 |
| 2022-12-31 | $3.87M 10-K · filed 2024-03-06 |
| 2022-09-30 | $5.93M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $8.17M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $10.87M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $11.41M 10-K · filed 2023-03-08 |
| 2021-09-30 | $11.97M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $11.75M 10-Q · filed 2021-08-19 |
| 2020-12-31 | $10.63M 10-K · filed 2022-03-09 |